These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior. Hedan B; Thomas R; Motsinger-Reif A; Abadie J; Andre C; Cullen J; Breen M BMC Cancer; 2011 May; 11():201. PubMed ID: 21615919 [TBL] [Abstract][Full Text] [Related]
5. T Lymphocytes in Histiocytic Sarcomas of Flat-Coated Retriever Dogs. Marcinowska A; Constantino-Casas F; Williams T; Hoather T; Blacklaws B; Dobson J Vet Pathol; 2017 Jul; 54(4):605-610. PubMed ID: 28129095 [TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinases expression in spontaneous canine histiocytic sarcomas and its xenograft model. Fayyad A; Lapp S; Risha E; Pfankuche VM; Rohn K; Barthel Y; Schaudien D; Baumgärtner W; Puff C Vet Immunol Immunopathol; 2018 Apr; 198():54-64. PubMed ID: 29571518 [TBL] [Abstract][Full Text] [Related]
7. Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs. Affolter VK; Moore PF Vet Pathol; 2002 Jan; 39(1):74-83. PubMed ID: 12102221 [TBL] [Abstract][Full Text] [Related]
8. Clinical prognostic factors in canine histiocytic sarcoma. Dervisis NG; Kiupel M; Qin Q; Cesario L Vet Comp Oncol; 2017 Dec; 15(4):1171-1180. PubMed ID: 27334037 [TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes in dogs with localized splenic histiocytic sarcoma treated with splenectomy with or without adjuvant chemotherapy. Latifi M; Tuohy JL; Coutermarsh-Ott SL; Klahn SL; Leeper H; Dervisis N J Vet Intern Med; 2020 Nov; 34(6):2645-2650. PubMed ID: 32986268 [TBL] [Abstract][Full Text] [Related]
10. Morphological Distinction of Histiocytic Sarcoma from Other Tumor Types in Bernese Mountain Dogs and Flatcoated Retrievers. Erich SA; Constantino-Casas F; Dobson JM; Teske E In Vivo; 2018; 32(1):7-17. PubMed ID: 29275293 [TBL] [Abstract][Full Text] [Related]
11. Identification of common predisposing loci to hematopoietic cancers in four dog breeds. Hédan B; Cadieu É; Rimbault M; Vaysse A; Dufaure de Citres C; Devauchelle P; Botherel N; Abadie J; Quignon P; Derrien T; André C PLoS Genet; 2021 Apr; 17(4):e1009395. PubMed ID: 33793571 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of the two-base insertion mutation in the TP53 gene in canine histiocytic sarcoma. Asada H; Tomiyasu H; Okada K; Chambers JK; Goto-Koshino Y; Uchida K; Kagawa Y; Ohno K; Tsujimoto H Res Vet Sci; 2019 Jun; 124():57-60. PubMed ID: 30852355 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines. Asada H; Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H J Vet Med Sci; 2015 Jun; 77(6):677-84. PubMed ID: 25715778 [TBL] [Abstract][Full Text] [Related]
14. A 2-base insertion in exon 5 is a common mutation of the TP53 gene in dogs with histiocytic sarcoma. Asada H; Tsuboi M; Chambers JK; Uchida K; Tomiyasu H; Goto-Koshino Y; Ohno K; Tsujimoto H J Vet Med Sci; 2017 Oct; 79(10):1721-1726. PubMed ID: 28867679 [TBL] [Abstract][Full Text] [Related]
15. Risk Factors Associated with Development of Histiocytic Sarcoma in Bernese Mountain Dogs. Ruple A; Morley PS J Vet Intern Med; 2016 Jul; 30(4):1197-203. PubMed ID: 27160025 [TBL] [Abstract][Full Text] [Related]
16. A review of histiocytic diseases of dogs and cats. Moore PF Vet Pathol; 2014 Jan; 51(1):167-84. PubMed ID: 24395976 [TBL] [Abstract][Full Text] [Related]
17. Gain-of-function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs. Thaiwong T; Sirivisoot S; Takada M; Yuzbasiyan-Gurkan V; Kiupel M Vet Comp Oncol; 2018 Jun; 16(2):220-228. PubMed ID: 28929581 [TBL] [Abstract][Full Text] [Related]
18. Influence of a survivin suppressor YM155 on the chemoresistance of canine histiocytic sarcoma cells. Yamazaki H; Takagi S; Hosoya K; Okumura M Vet J; 2015 Sep; 205(3):375-80. PubMed ID: 26048444 [TBL] [Abstract][Full Text] [Related]
19. Circulating tumor DNA is detectable in canine histiocytic sarcoma, oral malignant melanoma, and multicentric lymphoma. Prouteau A; Denis JA; De Fornel P; Cadieu E; Derrien T; Kergal C; Botherel N; Ulvé R; Rault M; Bouzidi A; François R; Dorso L; Lespagnol A; Devauchelle P; Abadie J; André C; Hédan B Sci Rep; 2021 Jan; 11(1):877. PubMed ID: 33441840 [TBL] [Abstract][Full Text] [Related]
20. Establishment and characterisation of cell lines and xenograft mouse models of canine systemic histiocytosis and disseminated histiocytic sarcoma. Hirabayashi M; Chambers JK; Kishimoto TE; Nguyen SV; Ishikawa Y; Rimpo K; Nakayama H; Uchida K Vet Comp Oncol; 2022 Jun; 20(2):465-475. PubMed ID: 34907644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]